<DOC>
	<DOC>NCT00772330</DOC>
	<brief_summary>Assess the safety and performance of the Miami InnFocus Drainage Implant in patients suffering from glaucoma that is inadequately controlled on tolerated medical therapy with intraocular pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg.</brief_summary>
	<brief_title>Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Male or female, age 18 to 85 years, inclusive Glaucoma that is inadequately controlled on tolerated medical therapy with intraocular pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg. Patient must have signed informed consent form Unwilling or unable to give informed consent or unable to return for scheduled protocol visits Pregnant or nursing women No light perception Active iris neovascularization or active proliferative retinopathy Iridocorneal endothelial syndrome Epithelial or fibrous downgrowth Aphakia (without pseudophakia) Vitreous in anterior chamber for which a vitrectomy is anticipated Chronic or recurrent uveitis Severe posterior blepharitis Unwilling to discontinue contact lens use after surgery Previous ophthalmic surgery, excluding uncomplicated phacoemulsification (cataract) surgery or corneal refractive surgery Need for glaucoma surgery combined with other ocular procedures other than cataract surgery (i.e., penetrating keratoplasty or retinal surgery) or anticipated need for additional ocular surgery Known allergy to Mitomycin C (MMC) drug.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>MIDI Arrow</keyword>
	<keyword>Glaucoma Drainage Device</keyword>
	<keyword>GDD</keyword>
	<keyword>InnFocus</keyword>
	<keyword>Glaucoma treatment</keyword>
</DOC>